D. Gareth Rees
AstraZeneca (United Kingdom)(GB)AstraZeneca (Singapore)(SG)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, IL-33, ST2, and ILC Pathways, Eosinophilic Esophagitis, Glycosylation and Glycoproteins Research, Immune Cell Function and Interaction
Most-Cited Works
- → Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation(2015)262 cited
- → Structural Characterisation Reveals Mechanism of IL-13-Neutralising Monoclonal Antibody Tralokinumab as Inhibition of Binding to IL-13Rα1 and IL-13Rα2(2016)192 cited
- → A combined microscopic-molecular method for the diagnosis of strongylid infections in sheep(2009)124 cited
- → Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction(2023)96 cited
- → A functionally specialized α-tubulin is required for oocyte meiosis and cleavage mitoses in Drosophila(1993)85 cited
- → Oxidised IL-33 drives COPD epithelial pathogenesisviaST2-independent RAGE/EGFR signalling complex(2023)73 cited